Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma.
about
Weighing the value of completion nodal dissection for melanoma.Regional control and morbidity after superficial groin dissection in melanomaSaphenous vein sparing superficial inguinal dissection in lower extremity melanoma.Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients.Prognosis in patients with sentinel node-positive melanoma without immediate completion lymph node dissection.Dissections of regional lymph nodes for treatment of skin cancer: predicting annual caseloads that will optimise outcomes.Outcome of patients with a positive sentinel lymph node who do not undergo completion lymphadenectomy.Nodal Basin Recurrence After Sentinel Lymph Node Biopsy for Melanoma: A Retrospective Multicenter Study in 2653 Patients.Impact of the Ultrasonic scalpel on the amount of drained lymph after axillary or inguinal lymphadenectomyRisk evaluation in cutaneous melanoma patients undergoing lymph node dissection: impact of POSSUM.The influence of sentinel lymph node tumour burden on additional lymph node involvement and disease-free survival in cutaneous melanoma--a retrospective analysis of 392 casesWound complications after inguinal lymph node dissection for melanoma: is ACS NSQIP adequate?Morbidity After Inguinal Lymph Node Dissections: It Is Time for a ChangeImplementing sentinel lymph node biopsy programs in developing countries: challenges and opportunities.Axillary lymph node dissection for malignant melanoma.Advances in sentinel lymph node mapping for patients with melanoma.Surgeons' opinions on lymphadenectomy in melanoma patients with positive sentinel nodes: a worldwide web-based survey.Videoscopic inguinal lymphadenectomy for metastatic melanoma.Malignant melanoma in elderly patients: biological, surgical and medical issues.Is the non-sentinel lymph node compartment the next site for melanoma progression from the sentinel lymph node compartment in the regional nodal basin?Morbidity and oncologic outcome after saphenous vein-sparing inguinal lymphadenectomy in melanoma patients.Assessment of morbidity following regional nodal dissection in the axilla and groin for metastatic melanoma.Detailed pathological examination of completion node dissection specimens and outcome in melanoma patients with minimal (<0.1 mm) sentinel lymph node metastases.Enhanced postoperative lymphatic staging of malignant melanoma by endoscopically assisted iliacoinguinal dissection.Endoscopic groin lymph node dissection as a preferable technique for malignant skin neoplasms.Assessment of lymphatic drainage patterns and implications for the extent of neck dissection in head and neck melanoma patients.Reliability and cost-effectiveness of complete lymph node dissection under tumescent local anaesthesia vs. general anaesthesia: a retrospective analysis in patients with malignant melanoma AJCC stage III.Morbidity and Outcomes Following Axillary Lymphadenectomy for Melanoma: Weighing the Risk of Surgery in the Era of MSLT-II.Impact of extended lymphadenectomy on morbidity and regional recurrence-free survival in melanoma patients.Effectiveness of intraoperative indocyanine-green fluorescence angiography during inguinal lymph node dissection for skin cancer to prevent postoperative wound dehiscence.Photodynamic Ablation of Lymphatic Vessels and Intralymphatic Cancer Cells Prevents Metastasis
P2860
Q30248851-72274015-95E6-4B91-8F3A-6FFD0D7CC7CBQ30356674-9C4B3EC1-042B-4A28-A3CC-E97511602732Q34003473-DAA12835-23D0-492A-82F7-CA0C8F1BB24AQ34143271-C49A75F3-B895-4891-9081-4D62F685FB5CQ34409481-5A0A2082-797B-476F-8859-78C47FD84F08Q35759550-65EF3AA5-2210-4C27-996B-D36AA7350EE3Q36088981-E5820DCB-1494-4FD2-B69E-4C8B4D43843FQ36194810-CDF1FD7A-1746-4C1A-B482-4C27D8251F2CQ36317418-3092B207-A5BD-4664-AA63-1D942D97E404Q36706776-679120D2-870D-497E-8DFC-E0CB57DB71ADQ36740669-A54BA772-2E76-4233-A43F-4F8510DDA163Q36853261-C53F13AE-3B82-40D9-8488-C1348FB2CC0DQ37560343-14DAF7E0-3A8F-445D-854E-7044B14AED28Q37832409-7AE1D2A6-46C1-46C1-B233-9B7B200AE34DQ37980464-B7B3DDB1-7AEC-4506-8AB7-BF5B50FFF3E3Q37984125-24142664-0555-46D4-9F27-F11B93F1C527Q38027028-0458290E-4A6A-47B8-BA89-D3BE43D36816Q38146705-AAA9755B-9232-4AD6-ACEC-EBF0CE874346Q38253484-783F304A-3F6E-468C-B61D-BEBB50F9C7C1Q38683103-730B335C-914C-43EB-8F35-BA3D9A781D27Q38793877-C1F5DB49-255B-4441-878B-3B82568256B9Q38877852-A665596A-FCC1-438E-A0EE-18A2EAC9BEE7Q40922293-6C96C242-62F1-4280-B1CD-EB5B4C1EDDACQ42629898-D4BA116C-C528-4568-BCD7-F95DF4AAAA4AQ44078311-669CDB58-6218-448E-865C-EF20C5DDFD81Q44229100-034C59EB-E393-4461-BE74-C0852FB9DACCQ45842383-3DE2C341-FB59-4C53-8911-6F743CF9F030Q47437708-DC218A62-0472-4839-9838-BBF2BE6B58CAQ48369437-1B01A6A2-B2E6-4428-B310-91E1FDFF2BA5Q50452268-555ABE51-E533-405B-8DBE-78C584CC6465Q57381940-E00AB6DC-7734-4617-9E7D-A8F95E4C1C3D
P2860
Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Morbidity and recurrence after ...... cutaneous malignant melanoma.
@en
Morbidity and recurrence after ...... cutaneous malignant melanoma.
@nl
type
label
Morbidity and recurrence after ...... cutaneous malignant melanoma.
@en
Morbidity and recurrence after ...... cutaneous malignant melanoma.
@nl
prefLabel
Morbidity and recurrence after ...... cutaneous malignant melanoma.
@en
Morbidity and recurrence after ...... cutaneous malignant melanoma.
@nl
P2093
P1433
P1476
Morbidity and recurrence after ...... cutaneous malignant melanoma.
@en
P2093
Florian J Jung
Matthias C Aust
Maurizio Calcagni
Merlin M Guggenheim
Pietro Giovanoli
Walter Künzi
P304
P356
10.1097/SLA.0B013E318161312A
P407
P577
2008-04-01T00:00:00Z